DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Biogen Idec

NASDAQ: BIIB

226.85 -1.14 (-0.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $226.85 -0.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $228.36
Previous Close $227.99
Daily Range $224.60 - $228.86
52-Week Range $126.39 - $231.99
Market Cap $53.8B
P/E Ratio 36.19
Dividend (Yield) $0.00 (0.0%)
Volume 1,243,879
Average Daily Volume 1,334,568
Current FY EPS $7.88

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

Buzz on the Street: This Bull Is Half Honey Badger, Half Terminator

AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward

Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard

2 Scariest Dividend Stocks in Health Care

The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarte

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter

Cramer's 'Mad Money' Recap: Stick With What Works

Isis Gets $3.5M Milestone Payment - Analyst Blog

Biogen Idec Stock Hits New 52-Week High (BIIB)

Diversifying Royalties at a Hefty Cost

Elan buys 21% of Thervance's royalties on Glaxo's lung drugs.

Today's 3 Best Stocks

A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.

See More BIIB News...

BIIB's Top Competitors

BIIB $226.85 (-0.50%)
Current stock: BIIB
AMGN $105.63 (0.63%)
Current stock: AMGN
GILD $56.30 (2.44%)
Current stock: GILD
$0.00 (0.00%)
Current stock: